VRTX News
Vertex Pharmaceuticals Incorporated
$530.76
-$22.39(-4.05%)
71
Overall
60
Value
90
Tech
63
Quality
Market Cap
$140.20B
Volume
2.37M
52W Range
$403.16 - $563.80
Target Price
$573.07
VRTX news: the latest Vertex Pharmaceuticals Incorporated headlines, press releases and market updates, newest first.
Latest VRTX News
- Barclays Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX)TipRanks Auto-Generated Intelligence Newsdesk · Nov 4, 2026
- Time to Diversify Out of SemiconductorsTheStreet Pro · Nov 3, 2026
- Analysts Are Bullish on These Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Jazz Pharmaceuticals (JAZZ)TipRanks Newsroom · Nov 3, 2026
- Cantor Fitzgerald Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX)TipRanks Auto-Generated Intelligence Newsdesk · Nov 3, 2026
- Vertex Pharmaceuticals (VRTX) Receives a Buy from ScotiabankTipRanks Auto-Generated Intelligence Newsdesk · Nov 3, 2026
- Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE), Inspire Medical Systems (INSP) and Vertex Pharmaceuticals (VRTX)TipRanks Newsroom · Nov 3, 2026
- The Week That Was, The Week Ahead: Macro and Markets, November 1Ran Melamed · Nov 1, 2026
- Vertex Advances New ADPKD Candidate With Fresh Phase 1 Study UpdateTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 30, 2026
- Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Vertex Pharmaceuticals (VRTX)TipRanks Newsroom · Oct 28, 2026
- Vertex Pharmaceuticals (VRTX) Gets a Buy from ScotiabankTipRanks Auto-Generated Intelligence Newsdesk · Oct 26, 2026
- Wall Street Analysts Are Bullish on Top Healthcare PicksTipRanks Newsroom · Oct 26, 2026
- Vortex Energy Extends €100,000 Digital Marketing Campaign to Boost Investor VisibilityTipRanks Canadian Auto-Generated Newsdesk · Oct 15, 2026
- Analysts’ Opinions Are Mixed on These Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Demant (OtherWILLF) and Biomea Fusion (BMEA)TipRanks Newsroom · Oct 15, 2026
- Bank of America Securities Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)TipRanks Auto-Generated Intelligence Newsdesk · Oct 12, 2026
- Vertex and Moderna Advance CF mRNA Therapy: What VX-522 Trial Completion Means for InvestorsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 9, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRTX | $530.76 | -4.0% | 2.37M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vertex Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW